CBM

Cambrex
NYSE

Real-time Quotes | Nasdaq Last Sale

59.99
0.00
0.00%
Delisted 09:30 02/27 EST
OPEN
--
PREV CLOSE
59.99
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
60.29
52 WEEK LOW
33.80
MARKET CAP
2.02B
P/E (TTM)
56.28
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CBM and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average CBM stock price target is 60.00 with a high estimate of 60.00 and a low estimate of 60.00.

EPS

CBM News

More
  • Lytx Reports "Largest-Ever" Investment In Video Telematics
  • Benzinga · 01/08 19:49
  • EF Education First Shortlists Bidders for Chinese Unit
  • Bloomberg · 01/08 08:23
  • Cambrex Announces Management Changes and Board Appointments
  • GlobeNewswire · 01/06 16:36
  • Merger Arbitrage Mondays - Thoma Bravo's Acquisition Of Instructure Includes A Go-Shop Provision
  • Seeking Alpha - Article · 12/09/2019 14:11

Industry

Pharmaceuticals
-1.22%
Pharmaceuticals & Medical Research
-1.40%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About CBM

Cambrex Corporation (Cambrex) is a life sciences company. It provides products and services for the development and commercialization of generic therapeutics. It operates through four segments, which are manufacturing facilities that have been aggregated as a single segment. Its manufacturing facilities are owned by the subsidiaries, including Cambrex Charles City, Inc., Cambrex Karlskoga AB and Cambrex Profarmaco Milano S.r.l. Its products consist of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. It delivers services, such as custom organic synthesis and process development; current good manufacturing practices (cGMP) manufacturing of API and intermediates from grams to hundreds of kilograms; cGMP analytical services; controlled substance research and development (R&D) and manufacture, Schedule II-V, and contract research. It has API R&D and cGMP facilities in the United States and Europe. It supplies over 90 generic APIs.
More

Webull offers kinds of Cambrex Corporation stock information, including NYSE:CBM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CBM stock news, and many more online research tools to help you make informed decisions.